Upgrade to SI Premium - Free Trial

Stifel Transfers Coverage on BioMarin Pharmaceutical Inc. (BMRN), Maintains Buy

August 6, 2018 4:21 PM
Stifel assumes coverage on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) with a Buy rating ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change New Coverage

Next Articles